Sean Michael Smith
CIK 1914769 · Interim CFO, Prin Acct Off · last filed 2023-08-14
Sean Michael Smith is an Interim CFO, Prin Acct Off who has filed 6 SEC Form 4 insider transactions across 1 company since 2022. The most recent filing, for NGNE, was dated Mar 4, 2024. Across all open-market trades the lifetime net is −$4.4K, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
6
-$4.4K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Neurogene Inc. (NLTX) Delisted | Interim CFO, Prin Acct Off | 5,409 | $13.96 | $75.5K | -$4.4K | 5 | 2023-08-14 |
Recent Filings
6 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-03-04 | NGNE | Notice (144) | −371 | -$13.6K | EDGAR |
| 2023-08-14 | Neurogene Inc. (NLTX) Delisted | Mixed | +3,677 | -$818 | EDGAR |
| 2023-02-03 | Neurogene Inc. (NLTX) Delisted | Mixed | +9,184 | -$2.0K | EDGAR |
| 2022-08-12 | Neurogene Inc. (NLTX) Delisted | Mixed | +3,345 | -$1.6K | EDGAR |
| 2022-08-04 | Neurogene Inc. (NLTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-03-03 | Neurogene Inc. (NLTX) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.